Please login to the form below

Not currently logged in
Email:
Password:

Merck Serono CEO joins L’Oreal board

Belén Garijo named independent director at beauty company

Belén Garijo Belén Garijo – the present CEO of Merck Serono – has been appointed to the board of beauty company L'Oreal.

Garijo, who took up her current role at pharma company Merck Serono in September last year, will now also serve as an independent director at L'Oreal for a period of four years.

Garijo joined Merck Serono as chief operating officer in 2011. In addition to her current role as CEO she has served as interim global head of R&D at parent company Merck KGaA since the departure of Annalisa Jenkins earlier this year.

Before joining Merck, Garijo served as senior VP, global operations region Europe at Sanofi. During her time at Sanofi, she also took on the role of global integration leader for the company's acquisition of the biotech Genzyme.

Prior to her career in the industry Garijo worked for six years as a practicing physician.

23rd April 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....

Infographics